Trademark: 88647584
Word
COSIMIA
Status
Dead
Status Code
606
Status Date
Monday, December 4, 2023
Serial Number
88647584
Mark Type
4000
Filing Date
Wednesday, October 9, 2019
Published for Opposition
Tuesday, September 8, 2020
Abandoned Date
Monday, December 4, 2023

Trademark Owner History
ROCHE MOLECULAR SYSTEMS, INC. - Owner At Publication

Classifications
9 Scientific equipment, apparatus and instruments, namely, genome sequencer for scientific, pharmaceutical and medical research purposes; scientific instruments for use in scientific research, namely, nucleic acid sequencers, imaging devices and analyzers; laboratory apparatus for sample preparation, amplification, mixing, hybridization, incubation, and washing, namely, arrays, beads, bead sets and flow cells; laboratory equipment, namely, devices for analysis of nucleic acids and for DNA sequencing; automated laboratory apparatus and systems, namely, sample loaders and bar code readers; downloadable software used for genotyping and gene expression microarrays for scientific, pharmaceutical and medical research purposes; downloadable software used in analyzing, managing and visualizing DNA sequencing data; downloadable software used for preparation of nucleic acids libraries; computer hardware and downloadable software for collecting, storing, analyzing and reporting biological information, and for sample tracking and managing projects, laboratory workflow and data, for use in the fields of scientific, diagnostic and clinical research and for clinical diagnostic purposes
5 In vitro diagnostic agents, namely, reagents and control solutions for analysis of biological samples, all for medical diagnostic purposes; reagents for medical diagnostic use; medical diagnostic assays and reagents for testing of biological samples; reagent kits consisting of enzymes, oligonucleotides, nucleic acids, natural and modified nucleotides, buffers, labels, and substrates for medical diagnostic purposes; medical diagnostic test kits comprising reagents for testing body fluids to determine fetal chromosomal abnormalities; chemical reagents, preparations and test kits for fetal nucleic acid analysis for medical use; diagnostic kits consisting primarily of reagents for nucleic acid detection and analysis for medical diagnostic purposes; reagents for medical diagnostic use and diagnostic kits comprised of medical diagnostic reagents and assays for use in connection with DNA sequencing and genetic analysis
1 In vitro diagnostic agents, namely, chemical control solutions for calibrating and monitoring the accuracy and function of instruments and test results, chemical additives, enzymes, reagents, organisms and proteins for use in science, research and industry; reagents for cell separation for scientific or research purposes; labeling reagents for scientific or research purposes; reagents for the processing, separation, isolation, enrichment, depletion, detection, screening, cultivation, analysis and counting of material, in particular of chemicals and biological material, all for scientific or research purposes; reagents featuring magnetic beads for scientific or research purposes; antibody reagents for scientific or research purposes; buffer solutions and reagents for use with laboratory apparatus, namely, separation apparatus and analysis apparatus, for scientific or research purposes; reagents for processing biological material, namely, tissue, bone marrow, cells, blood and components thereof for scientific or research purposes; reagents, enzymes, and nucleotides for nucleic acid sequencing for scientific or research purposes; diagnostic tests comprised of reagents and chemical test kits for determination of genetic information for scientific or research purposes; reagents for scientific or medical research use for analyzing cells, proteins, nucleic acids, sequencing DNA, genotyping, gene expression profiling and high through-put screening; reagent kits composed primarily of oligonucleotides, enzymes and buffers for nucleic acid detection in the fields of scientific, pharmaceutical and medical research; nucleic acids, enzymes, buffers and chemical reagents for use in genotyping and gene expression test kits for detecting and analyzing nucleic acids for scientific or research purposes; assays and reagents for scientific or medical research use; diagnostic tests and test kits primarily composed of reagents and nucleotides for determination of genetic information for scientific or research purposes; reagents and chemical test kits for scientific and research use in connection with DNA sequencing and genetic analysis
10 Clinical or medical diagnostic apparatus and instruments, namely, nucleic acid sequencers, imaging devices and analyzers; medical diagnostic apparatus and instruments for the amplification and analysis of nucleic acids and the preparation of nucleic acid libraries sold together in the form of kit; medical equipment, namely, devices for analyzing nucleic acids and for DNA sequencing for the purpose of rendering medical treatment and diagnosis, and downloadable software for use therewith sold as a unit
42 Scientific research in the field of genome sequence analysis and reporting; medical research in the field of genome sequence analysis and reporting; DNA screening for scientific research purposes; providing reagent sample testing services for others in the fields of science and scientific research; computer services, namely, cloud hosting provider services for storing, analyzing and sharing biological information; computer services, namely, hosting an interactive web site that allows users to store, analyze and share data in the field of life science; technical support services, namely, infrastructure management services for monitoring, administration and management of cloud computing it and application systems in the field of life science; consulting services in the field of cloud computing in the field of life science; providing online non-downloadable software for the custom design and ordering of assays and reagents; design and development of laboratory apparatus, instruments and computer systems for use in analysis of biomolecules; installation and maintenance of computer software and database systems used in the field of analysis of biomolecules; consultancy, information and advisory services in the field of scientific analysis of biomolecules; product development, namely, developing equipment for use in preparing, detecting, analyzing and sequencing nucleic acids and other biological molecules, and automated laboratory equipment and systems, and computer systems for collecting, storing, analyzing and reporting biological information, and for sample tracking and managing projects, laboratory workflow and data to the order and specification of others, all the foregoing in the fields of scientific and clinical research; clinical diagnostic services in preparing, amplifying, labeling, detecting, analyzing and sequencing nucleic acids and other biological molecules from human beings or animals for scientific and medical research purposes; design and development of medical diagnostic apparatus and instruments and computer systems for use in analysis of biomolecules; scientific consulting and research services and clinical laboratory testing services in the fields of amplification, detection, sequencing and analysis of nucleic acids and the preparation of nucleic acid libraries; nucleic acid sequencing services for scientific research purposes; scientific research, namely, computational analysis of nucleic acid sequences and development of computational technologies for the analysis of nucleic acid sequences and instruments for the amplification and analysis of nucleic acids and the preparation of nucleic acid libraries sold together in the form of kit

Trademark Events
Dec 4, 2023
Abandonment Notice E-Mailed - No Use Statement Filed
Dec 4, 2023
Abandonment - No Use Statement Filed
May 2, 2023
Notice Of Approval Of Extension Request E-Mailed
May 1, 2023
Sou Extension 5 Granted
Apr 26, 2023
Sou Extension 5 Filed
May 1, 2023
Case Assigned To Intent To Use Paralegal
Apr 26, 2023
Sou Teas Extension Received
Oct 27, 2022
Notice Of Approval Of Extension Request E-Mailed
Oct 25, 2022
Sou Extension 4 Granted
Oct 25, 2022
Sou Extension 4 Filed
Oct 25, 2022
Sou Teas Extension Received
Apr 9, 2022
Notice Of Approval Of Extension Request E-Mailed
Apr 7, 2022
Sou Extension 3 Granted
Apr 7, 2022
Sou Extension 3 Filed
Apr 7, 2022
Sou Teas Extension Received
Oct 28, 2021
Notice Of Approval Of Extension Request E-Mailed
Oct 26, 2021
Sou Extension 2 Granted
Oct 26, 2021
Sou Extension 2 Filed
Oct 26, 2021
Sou Teas Extension Received
Apr 20, 2021
Notice Of Approval Of Extension Request E-Mailed
Apr 16, 2021
Sou Extension 1 Granted
Apr 16, 2021
Sou Extension 1 Filed
Apr 16, 2021
Sou Teas Extension Received
Nov 3, 2020
Noa E-Mailed - Sou Required From Applicant
Oct 19, 2020
Applicant/Correspondence Changes (Non-Responsive) Entered
Oct 19, 2020
Teas Change Of Correspondence Received
Oct 19, 2020
Attorney/Dom.Rep.Revoked And/Or Appointed
Oct 19, 2020
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Oct 19, 2020
Teas Change Of Owner Address Received
Sep 8, 2020
Official Gazette Publication Confirmation E-Mailed
Sep 8, 2020
Published For Opposition
Aug 19, 2020
Notification Of Notice Of Publication E-Mailed
Jul 30, 2020
Approved For Pub - Principal Register
Jul 7, 2020
Teas/Email Correspondence Entered
Jul 7, 2020
Correspondence Received In Law Office
Jul 6, 2020
Assigned To Lie
Jun 25, 2020
Notice Of Revival - E-Mailed
Jun 24, 2020
Teas Response To Office Action Received
Jun 24, 2020
Petition To Revive-Granted
Jun 24, 2020
Teas Petition To Revive Received
Dec 21, 2019
Notification Of Non-Final Action E-Mailed
Dec 21, 2019
Non-Final Action E-Mailed
Dec 21, 2019
Non-Final Action Written
Dec 13, 2019
Assigned To Examiner
Nov 27, 2019
Attorney/Dom.Rep.Revoked And/Or Appointed
Nov 27, 2019
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Oct 15, 2019
New Application Office Supplied Data Entered
Oct 12, 2019
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24